Denosumab-Mepha osteo 60 mg/ml
Denosumab-Mepha osteo 60 mg/ml is a medicine authorised by Swissmedic under authorisation number 70066. The authorisation holder is Mepha Pharma AG. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 26 November 2025 and the authorisation is limited until 25 November 2030. ATC code M05BX04 places the medicine in the group Drugs for treatment of bone diseases.
| Authorisation number | 70066 |
|---|---|
| Name | Denosumab-Mepha osteo 60 mg/ml |
| Full name | Denosumab-Mepha osteo 60 mg/ml, Injektionslösung in einer Fertigspritze |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | B · Prescription only |
| ATC code | M05BX04 |
| First authorisation | 26 November 2025 |
| Authorisation validity | 25 November 2030 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Denosumab-Mepha osteo 60 mg/ml, Injektionslösung in einer Fertigspritze | B | 26 November 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Fertigspritze(n) | M05BX04 | 07.99.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Denosumab-Mepha osteo 60 mg/ml authorised in Switzerland?
Yes. Denosumab-Mepha osteo 60 mg/ml is authorised by Swissmedic under authorisation number 70066, data as of 01 September 2026. The authorisation is limited until 25 November 2030.
Which dispensing category does Denosumab-Mepha osteo 60 mg/ml have?
Denosumab-Mepha osteo 60 mg/ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Denosumab-Mepha osteo 60 mg/ml?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.